Company intelligence / Profile preview

Benta Pharma Industries

Ownership: Public · BPI
Development stage: Other

Overview

Benta Pharma Industries manufactures high-quality pharmaceuticals and medical devices across multiple therapeutic areas. The company produces both traditional small molecules and biotech/sterile products. It has established itself as an industry leader in Lebanon with a broad portfolio targeting major disease categories. No specific clinical trial results are disclosed.

Therapeutic areas: NeurologyDermatologyMen's HealthEndocrinologyOncologyOtherImmunologyCardiovascular
Modalities: Small moleculeBiologicSterile injectablesEnhanced formulations
Industry: Biotech

Financials

Market cap: $3.4M
Enterprise value: $3.4M

Beyond the preview

Go deeper on Benta Pharma Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benta Pharma Industries.

Explore the full profile